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Abstract 
Background - Type 2 Diabetes Mellitus (T2DM) is a growing crisis that can lead to 
more problems if left untreated.  One of these problems includes diabetic nephropathy 
or Chronic Kidney Disease (CKD).  While there have been many advances in the field of 
treating CKD with medication, there are currently no medications with the capability of 
stopping the progression of or reversing diabetic nephropathy; however, recent studies 
have shown that diabetic nephropathy can be stopped and even reversed through 
dietary interventions.  One of these studies went through the effects of a low protein diet 
on diabetic nephropathy and found very promising results.  This meta-analysis was 
designed to explore the effects of a Low Carbohydrate Diet (LCD) on diabetic 
nephropathy. 
Methods - An electronic search of PubMed and Google Scholar was conducted.  To be 
considered eligible the studies had to contain (‘carbohydrate’ OR ‘carbohydrates’) AND 
(‘diet’ OR ‘diets’) AND (‘type 2’) AND (‘diabetes’ OR ‘diabetic’) AND (‘ketogenic’). The 
studies also had to measure Estimated Glomerular Filtration Rate (eGFR) and Glycated 
Hemoglobin (HbA1c).  Statistics and calculations were performed by Review Manager 
version 5.3 while risk of bias was assessed using the Robvis ‘risk of bias’ tool. 
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Findings - 262 potential articles were identified by the search and 10 studies matched 
the search criteria with a total of 921 participants (450 were given the LCD and 471 
were given control diets).  Analysis of the total Standardized Mean Difference (SMD) for 
the eGFR studies showed that there was no difference between the LCD and the 
control (total SMD: -0.00; 95% CI, -0.20 to 0.19; P = 0.97).  Analysis of the serum 
creatinine showed similar results (SMD: 0.13; 95% CI, -0.12 to 0.38; P = 0.31).  The 
total SMD for the HbA1c (SMD: -0.29; 95% CI, -0.55 to -0.03; P = 0.03) showed that 
there was a lowering of the HbA1c in the LCD and not in the control diet.  
Conclusion - In this meta-analysis there was no connection found between 
eGFR/serum creatinine and percent carbohydrates in the diets indicating the LCD did 
not negatively affect the kidneys.  HbA1c was found to be lower in the LCD than in the 
control which points to a LCD possibly leading to the reversal of T2DM which would 
remove the main cause of diabetic nephropathy. 
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Introduction 
The occurrences of Type 2 Diabetes Mellitus (T2DM) have been on the rise 
worldwide.  The Center for Disease Control (CDC) states that the rate of diabetes has 
risen from 2.39 million diabetics in 1965 to an estimated 34.2 million diabetics in just the 
U.S. in 2020 (1,2).  Viewed another way, diabetics used to be 1.27 percent of the U.S. 
population fifty-five years ago but are now 10.5 percent (1,2).  The current trend 
predictions indicate that by the year 2060 one out of every six adults in the U.S. will be 
diagnosed with diabetes.  In addition, The National Diabetes Statistics Report for 2020 
states that over 88 million adults in the U.S. alone are prediabetic and at a high risk of 
becoming diabetic soon (1). 
Type 2 diabetes is caused when the body’s blood glucose levels are kept high 
continuously for a long time (3).  This causes the cells in the body to become resistant 
to insulin, a protein used to tell cells to absorb glucose from the bloodstream, to the 
point where the β-cells of the pancreas cannot produce enough insulin to maintain 
glucose homeostasis (3).  According to the CDC, this imbalance in glucose levels can 
result in cardiovascular disease, retinopathy, neuropathy, nephropathy, and many more 
problems (4). 
Of these long-term complications of diabetes, diabetic nephropathy, also known 
as Chronic Kidney Disease (CKD), has become of notable concern due to its growing 
number of incidences.  While there are treatments and recommendations to relieve 
symptoms and slow down the progression of CKD, there are currently no known options 
available to reverse or even stop its progression.  At the end stages of CKD, diabetic 
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patients are only left with options of dialysis or kidney transplants (5).  With such a grim 
prognosis, more options for better treatment are greatly needed. 
Diabetic nephropathy has three primary causes, an increased pressure state, 
mesangial expansion, and nephron ischemia (6).  An increased pressure state can be 
caused by either vasoconstriction of the efferent blood vessels in the kidney or overall 
hypertension in the body (6, 7).  This is most commonly measured as an increased 
Glomerular Filtration Rate (GFR) and is usually only able to be measured in the early 
stages of CKD (6, 7).  Mesangial expansion is the mesangial cells of the kidney 
increasing in size to the point where the fenestrations (pores in the podocytes) are large 
enough to allow proteins and other large molecules to pass through (8, 9).  This is 
detected by an increase in proteinuria (protein in the urine) (6, 7).  Nephropathy is 
defined as the atrophy of nephrons and is usually found at the last stage of kidney 
disease and can be caused by nephron ischemia (6, 7).  Nephron ischemia is the lack 
of blood flow to the kidney cells due to a reduction in the diameter of the blood vessels 
(6, 7, 10).  This is commonly detected as a decrease in GFR (6, 7).  It has been 
estimated that nearly 40% of all diabetics will eventually develop CKD leading it to 
become a major public health concern (5). 
Over the past fifty years, there have been great achievements in drug 
development to provide options to lower blood glucose levels, decrease proteinuria, and 
even help lower hypertension in diabetics; However, even with these drugs, diabetic 
nephropathy still slowly progresses in the patients (5, 11).  This slow progression still 
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seems to end in End Stage Renal Disease (ESRD) which can currently be treated with 
only dialysis or replacement of the kidneys (5). 
Newer studies have shown options for treating diabetic nephropathy and even 
ESRD through diet.  A meta-analysis on the effects of low protein diets showed that the 
low protein diet had a significant improvement of renal function in patients with differing 
stages of renal disease (12).  The study showed that the GFR of patients on the low 
protein diet significantly improved while adverse effects such as decreasing glycemic 
control and malnutrition were not seen during the study’s duration (12).  While there is 
still much to be studied in the field of diet and nutrition on type 2 diabetics and diabetic 
nephropathy, new research shows that diet is capable of reducing the effects of and 
even reversing kidney damage especially in type 2 diabetics (8, 13).  Unfortunately, in 
many of these studies, the food intake parameters were not well-defined which results 
in conflicting reports and outcomes.  The goal of this research is to conduct a 
systematic review and meta-analysis of studies on moderately-low, low, and very low 
carbohydrate diets with type 2 diabetics in order to find the most effective dietary 
parameters to reduce and possibly halt the progression of nephropathy while also 
stopping or reversing the effects of diabetes in the patients.  This will be done by 
examining the results of many studies that show the function of the kidney through 
estimated GFR (eGFR) or serum creatinine and the state of diabetes in the patient 
through their glycated hemoglobin (HbA1c).  
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Methods 
 The following methods are designed to closely follow the PRISMA (Preferred 
Reporting Items for Systematic reviews and Meta-Analyses) checklist for systematic 
reviews and meta-analyses (14). 
 
Data Sources and Searches 
Literature search was conducted using the electronic databases Google Scholar 
and PubMed.  The search included articles published from inception through February 
2020.  Articles selected were written in English and included the search terms: 
(‘carbohydrate’ OR ‘carbohydrates’) AND (‘diet’ OR ‘diets’) AND (‘type 2’) AND 
(‘diabetes’ OR ‘diabetic’) AND (‘ketogenic’).  The date last searched was March 13, 
2020. 
 
Study Selection 
Among the studies identified, only studies that included type 2 diabetics and that 
measured GFR, eGFR, or serum creatinine were included.  In addition, at least one arm 
of the study had to include the use of a Moderately Low Carbohydrate Diet (MLCD), a 
Low Carbohydrate Diet (LCD), or a Very Low Carbohydrate Diet (VLCD) as part of the 
trial. 
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Data Synthesis and Analysis 
Data extracted from the studies included: study title, authors, publication date, 
sample size, dropout rate, length of study, interventions, average age of the study 
group, the study design, duration of the study, and outcomes. Outcomes from the study 
were combined using Review Manager (RevMan) version 5.3 (15). The random effects 
model was used for the combined outcomes of these studies. Inverse variance was 
used for the statistical analysis.  Standardized Mean Difference (SMD) and 95% 
Confidence Intervals (CI) were used in presenting the data.  Heterogeneity was 
assessed using the I2 statistic.  All previously listed calculations were performed by 
RevMan version 5.3. 
 In this meta-analysis, Creatinine Clearance Rate (CCR) and GFR were 
considered as eGFR.  Standard Deviation (SD) was calculated by hand using the 
formula outlined in the Cochrane Handbook (16) (Equation 1).  Conversion of serum 
creatinine from µmol/L to mg/dL was performed by hand (Equation 2). 
Equation 1 - Equation for standard deviation using a 95% confidence interval 
 
SD = √(N) * (upper limit – lower limit)/3.92 
 
Equation 2 - Conversion of serum creatinine from µmol/L to mg/dL 
 
Serum Creatinine (µmol/L) * 0.011312 = Serum Creatinine (mg/dL) 
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Publication Bias 
 Risk of bias was assessed by using the Robvis ‘risk of bias’ assessment tool 
(17).  Potential risk of bias included: sequence generation, allocation concealment, 
blinding of participants, personnel and outcome assessors, incomplete outcome data, 
and selective outcome reporting.  An evidence based high, low, or unclear bias 
assessment was made for the domains after a thorough study of each article. 
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Results 
Search Results 
A review of Google Scholar and PubMed listed 262 potential articles for the 
meta-analysis (Figure 1).  Of them, 150 records were excluded due to their abstract not 
meeting the search criterial.  An additional 42 articles were duplicate articles.  Of the 
remaining 70 articles, 56 of these studies did not measure eGFR, GFR, or serum 
creatinine and were removed.  Another 4 studies were set aside because they lacked 
controls.  A final total of 10 studies were included for this review. 
 
Characteristics of Studies and Participants 
The 10 selected studies included a total of 921 type 2 diabetic patients (Table 1).  
The average age of the participants ranged between 50 and 69 years old.  The length of 
the studies varied from 5 weeks to 24 months.  The studies stated the percentage of 
carbohydrates, proteins, and fats were typically consumed in a day for both the low 
carbohydrate and control diets.  Of the ten studies, five contained data on eGFR, six 
contained data on serum creatinine levels, and eight contained data on HbA1c.  Also 
noted in the studies was whether the renal function of the patient was impaired at the 
start of the study (Table 1). 
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Figure 1 - PRISMA flow diagram of selection of studies 
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Study Diet Characteristics 
For this meta-analysis the diets containing 45% of caloric intake as 
carbohydrates (carbs) and lower were considered as low carb.  The controls of the 
studies varied between 48% carbs and 57% with the exception of the study by 
Westman et. al. which had a control of 44% carbs and a Low Carb Diet (LCD) with 13% 
carbs.  Most of the studies gave the participants a restriction list of what the patients 
could eat from and the patients were to return with journaled entries of what they ate or 
were to keep in contact with the study designers every one to three weeks.  This was 
done to make the diets easy for the patients to stay on and to reduce the dropout rate 
that is normally high with restricted dietary studies. 
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Table 1 - Main characteristics of the studies included in the meta-analysis. No Data (ND), Standard 
Deviation (SD), n = number of participants, Carbohydrates% / Proteins% / Fats% = C/P/F 
References 
Study 
Length 
Intervention 
Low Carb n C/P/F 
Control n C/P/F 
Baseline - Final 
Low Carb 
eGFR(SD) 
Control 
eGFR(SD) 
Baseline - Final 
Low Carb 
Creatinine(SD) 
Control 
Creatinine(SD) 
Baseline - Final 
Low Carb 
HbA1c(SD) 
Control 
HbA1c(SD) 
Average 
Age 
Impaired 
Renal 
Function? 
Ruggenenti 
et al 
2017 
6m 
n=34  44/22/36 
n=36  48/18/34 
107.8(21.0) - 
100.2(16.5) 
109.2(19.0) - 
106.5(20.2) 
ND 
6.8(1.0) - 6.3(0.7) 
6.6(0.7) - 6.8(1.0) 
59.8 
59.8 
No 
Larsen et al 
2011 
12m 
n=53  40/30/30 
n=46  55/15/30 
70.2(11.9) - 
73.4(11.9) 
72.6(14.2) - 
74.6(14.2) 
ND 
7.9(0.5) - 7.7(0.5) 
7.8(1.0) - 7.5(1.0) 
59.6 
58.8 
No 
Krebs et al 
2011 
24m 
n=144  40/30/30 
n=150  55/15/30 
ND 
0.89(0.29) - 
0.94(0.27) 
0.84(0.21) - 
0.89(0.25) 
8.1(1.2) - 8.2(1.5) 
8.0(1.2) - 8.1(1.4) 
57.7 
58.0 
No 
Haimoto et al 
2007 
24m 
n=45  45/18/33 
n=57  57/16/26 
ND 
0.86(0.20) - 
0.73(0.22) 
0.86(0.17) - 
0.70(0.16) 
7.4(1.1) - 6.7(0.6) 
7.1(1.0) - 7.5(1.3) 
64.0 
69.0 
No 
Yamada et al 
2013 
6m 
n=12  30/25/45 
n=12  51/17/32 
69.0(14.5) - 
69.4(15.0) 
69.1(13.2) - 
65.0(12.6) 
ND 
7.6(0.4) - 7.0(0.7) 
7.7(0.6) - 7.5(1.0) 
63.3 
63.2 
No 
Sato et al 
2016 
6m 
n=30  45/20/35 
n=32  52/17/31 
ND 
0.78(0.45) - 
0.75(0.45) 
0.68(0.35) - 
0.70(0.26) 
8.0(1.8) - 7.3(2.2) 
8.3(1.9) - 8.3(1.7) 
60.5 
58.4 
No 
Nuttall et al 
2005 
5wk 
n=8  20/30/50 
n=8  55/15/30 
ND 
0.90(0.05) - 
1.0(0.05) 
0.90(0.10) - 
0.90(0.05) 
UNCLEAR 
63.0 
63.0 
No 
Westman et 
al 
2008 
6m 
n=21  13/28/59 
n=29  44/20/36 
ND ND 
8.8(1.8) - 7.3(1.5) 
8.3(1.9) - 7.8(2.1) 
51.2 
50.0 
No 
Tay et al 
2015 
12m 
n=58  14/28/58 
n=57  53/17/30 
96.0(11.7) - 
92.0(11.7) 
92.0(11.6) - 
90.0(11.6) 
0.78(0.16) - 
0.81(0.17) 
0.80(0.17) - 
0.83(0.17) 
ND 
58.0 
58.0 
No 
Goday et al 
2016 
4m 
n=45  25/64/11 
n=44  50/20/30 
75.6(17.4) - 
75.6(17.4) 
74.9(14.5) - 
74.9(14.5) 
0.90(0.17) - 
0.90(0.17) 
0.92(0.28) - 
0.92(0.28) 
6.9(1.1) - 6.0(0.7) 
6.8(1.1) - 6.4(0.8) 
54.5 
54.9 
No 
 
  
11 
Outcome 
 This meta-analysis will show some clinical heterogeneity due to the study 
designs being different for each diet.  This is especially true in studies that allowed the 
patients to select their own food while keeping a food journal of what they consumed.  
Heterogeneity is classified as P < 0.05 and the amount of heterogeneity is defined as I2 
= X% (X < 25% = low, 25% < X < 75% = moderate, and 75% < X = high). 
 
The Effects of Low Carbohydrate Diet on eGFR 
 The five studies used in the analysis of the effects of LCD on eGFR contained a 
total of 397 patients and showed no difference between the control and the LCD (19, 
20. 23, 26, 27).  The analysis of the effect of a low carbohydrate diet on eGFR in type 2 
diabetic patients showed no heterogeneity (P = 0.46, I2 = 0%) (Figure 2).  This is 
because the eGFR between the control and the low carbohydrate diets were not 
significantly different (total SMD: -0.00; 95% CI, -0.20 to 0.19; P = 0.97) (Figure 2).  
Analysis of the change in eGFR vs percent carbohydrates also reflects that there is no 
difference between the change in eGFR in both low carb vs control (Figure 5). 
 
The Effects of Low Carbohydrate Diet on Serum Creatinine 
 The six studies used in the analysis of the effects of LCD on serum creatinine 
contained a total of 678 patients and showed no difference in the serum creatinine in 
the low carb vs the control diets (21, 22, 24, 25, 26, 27).  Analysis of the effect of a low 
carbohydrate diet on serum creatinine in type 2 diabetic patients showed a moderate 
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amount of heterogeneity (P = 0.05, I2 = 54%) (Figure 3); however, this heterogeneity 
comes primarily from an outlier study, possibly due to the very short (5 week) duration 
of the study (25).  The test for the overall effect showed no difference between the two 
diets (SMD: 0.13; 95% CI, -0.12 to 0.38; P = 0.31) (Figure 3).  Analysis of the graph 
showing the change in serum creatinine vs percent carbohydrates also provided no 
evidence of a difference between the low carb and the control diets (Figure 6). 
 
The Effects of Low Carbohydrate Diet on HbA1c 
 The eight studies used in the analysis of the effects of LCD on HbA1c contained 
a total of 758 patients and showed that HbA1c was lowered when on the low carb diet 
(18, 19, 20, 21, 22, 23, 24, 27).  The analysis of the effect of a low carbohydrate diet in 
type 2 diabetic patients on HbA1c is similar to the serum creatinine in that it also 
contains moderate heterogeneity (P = 0.007, I2 = 64%) (Figure 4); however, the meta-
analysis of these studies showed a significant difference between the low carbohydrate 
and the control which was the HbA1c favoring the low carbohydrate diet (SMD: -0.29; 
95% CI, -0.55 to -0.03; P = 0.03) (Figure 4).  The graph showing the change in HbA1c 
also reflects this with both trendlines becoming more negative as the percent 
carbohydrates became lower (Figure 7). 
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Figure 2 – Effects of a low carbohydrate diet on eGFR in T2D subjects 
 
 
 
Figure 3 – Effects of low carbohydrate diet on serum creatinine in T2D subjects 
 
 
 
Figure 4 – Effects of low carbohydrate diet on HbA1c T2D subjects 
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Figure 5 – Graph showing the change in eGFR vs percent carbohydrates in both low carb and control diets 
 
 
Figure 6 – Graph showing change in serum creatinine vs percent carbohydrates for both low carb and control diets 
15 
 
Figure 7 – Graph showing the change in HbA1c vs the percent carbohydrates with both control and low 
carb diets. 
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Figure 8 - Risk of bias summary 
 
Publication Bias Assessment 
 Analysis of the studies showed little risk of bias (Figure 8).  The allocation 
concealment was determined to not influence publication bias due to the patients 
knowing what diet they were on as soon as they received the food. 
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Discussion 
Summary of Results 
 The objective of this meta-analysis was to investigate the impact of a low-carb 
diet on kidney function in type 2 diabetics.  This was done because type 2 diabetics 
have a high blood sugar which has been shown to cause damage to renal function.  
Renal function is best measured with GFR; however, most studies provide only eGFR 
or serum creatinine which can both give an estimate on renal function.  The National 
Kidney Foundation lists the values of GFR and their corresponding relationship with 
renal functions (Table 2).  The state of a diabetic can be estimated through their HbA1c 
levels which is the amount of glycated hemoglobin in comparison to the total amount of 
hemoglobin.  Figures provided by the CDC shows at what stages HbA1c is related to 
diabetes (Table 3). 
 The results of the search showed a very small amount of studies on the topic 
area.  The majority of these studies were on weight loss by dietary intervention rather 
than how the LCD affected the renal system.  One of the included studies did not 
provided values for eGFR or creatinine but did state that the values did not change 
during the course of the study (18).  The meta-analysis of the rest of the data showed 
that eGFR does not change when measured from LCDs or control diets.  This could be 
due to the relatively short time frame as most of the studies were done in under a year.  
A change in eGFR was also checked to see if a LCD would produce a greater change in 
kidney function than the control diet.  This produced Figure 5 which shows that 
regardless of the amount of carbohydrates in the diet, eGFR did not change.  Serum 
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creatinine showed similar results, with the exception of a moderately high heterogeneity 
(I2 = 54%) (Figure 3).  This was from the shortest duration study (5 weeks) which might 
not have been enough time for the diet to have a notable effect on renal function (25).  
A graph showing the change in serum creatinine (Figure 6) was also created to check 
the results of the eGFR and confirmed the results found in the eGFR graph (Figure 5).  
HbA1c was also examined in this meta-analysis to confirm the patients’ diabetic state.  
All the studies containing data on HbA1c showed that the patients were on average pre-
diabetic or diabetic.  The meta-analysis of this data showed that HbA1c was on average 
lowered in patients who were on the LCD.  The amount of carbohydrates consumed 
seemed to be the main factors in determining the change in HbA1c.  The HbA1c graph 
(Figure 7) shows this correlation nicely. 
 An interesting study showed that mice with either Akita or db/db diabetic 
nephropathy when put on a ketogenic diet (5% carbohydrates, 8% proteins, and 87% 
fats) and compared to the mice on the control diet (64% carb, 23% protein, and 11% 
fat).  The researchers found that the diabetic nephropathy was completely reversed 
within two months (8).  Since this research was done in mice, it was not incorporated 
into this meta-analysis; however, ketogenic diets have been shown in humans to 
produce positive results such as lower amount of seizures in people with epilepsy and 
weight loss in obese patients (27, 33).  This data was very promising and lead to the 
initiation of this meta-analysis.  After an extensive search, very little data like this could 
be found in humans as most of the trials did not contain patients with diabetic 
nephropathy.  The studies that were found to contain data similar to the mice study, did 
not have a control arm in the study and were not able to be incorporated in the meta-
19 
analysis.  These studies are listed in the references should the reader wish to look at 
the results of these studies (28, 29, 30). 
Limitations of Study 
 The meta-analysis, as used in this study, is designed to take data from multiple 
small studies and compile that data into a single study so that the new study has a 
much larger data pool to draw from.  This allows for a more conclusive result to be 
determined.  This drawing from multiple sources, however, has a few drawbacks.  
These drawbacks include a lack of consistency as to what is considered the control 
group, how long the study duration should be, what the results should be measured in, 
and how the treatment should be administered.  This meta-analysis had similar 
limitations in that most of the low carb diets were between 25% and 45% carbohydrates, 
however, some studies were between 20% and 13% carbohydrates making those 
studies very low carbohydrate studies by current standards.  Another limitation was that 
six of the ten studies used in this meta-analysis were conducted in under a year which 
would not allow for notable renal dysfunction to occur.(18, 19, 23, 24, 25, 27)  A third 
limitation with this study was the subjectivity of the food journals as they were kept by 
the participants themselves. 
Conclusion 
 This meta-analysis investigated the effect of a low-carb diet on renal function.  
The results of this study have shown that the eGFR and serum creatinine were not 
different between patients in the control arm and in the low carb arm of the study.  This 
provides evidence that renal function was not negatively impacted by the low 
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carbohydrate diet.  The HbA1c, however, was lowered when the percent of 
carbohydrates was lowered which could lead to the reversal of T2DM.  Since these 
studies were done in the short term, a longer trial duration with a greater number of 
participants should be done before conclusive evidence can be stated about a low carb 
diet.  Future research should also focus on very low carb diets and renal function as a 
study by Poplawski showed that diabetic nephropathy was able to be reversed through 
a ketogenic diet (13).  Another focus of research should include the effects of a 
ketogenic diet on liver function of type 2 diabetics due to the low carbohydrates possibly 
stimulating gluconeogenesis in the liver. 
 
Table 2 – Stages of CKD (National Kidney Foundation guidelines) (31)
  
Table 3 – Stages of T2DM (CDC Managing Diabetes guideline) (32)
 
  
Stage Description 
GFR  mL/min/1.73 m2 body 
surface area 
1 
Kidney damage* with normal or 
increased GFR 
≥ 90 
2 
Kidney damage* with mildly decreased 
GFR 
60-89 
3 Moderately decreased GFR 30-59 
4 Severely decreased GFR 15-29 
5 Kidney failure < 15 or dialysis 
* Kidney damage defined as abnormalities on pathologic, urine, blood, or imaging test 
Diagnosis HbA1c level 
Normal Below 5.7% 
Prediabetes 5.7% to 6.4% 
Diabetes 6.5% or greater 
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